VWR Acquires Therapak

RADNOR, Pa., Jan. 6, 2016 /PRNewswire/ -- VWR (NASDAQ: VWR), a leading, global,  independent provider of laboratory products, services and solutions, announced today that it has acquired Therapak Corporation and Therapak Pharma Services Limited, suppliers of pre-packaged convenience kits and procedure packs for the clinical trial, pharmaceutical, diagnostic and clinical laboratory industries. This acquisition will strengthen VWR's product and service offering and provide its customers with valuable additional solutions capabilities to achieve its goals.

"We are pleased to be part of VWR's extensive supply chain for products and services," said Todd Gates, President of Therapak. "We look forward to accelerating our development and reach with a trusted, global organization like VWR."

"As a previous supplier to VWR, Therapak has proved to be a leader of procedure and kit assembly, making them a great asset to our organization," said Mark McLoughlin, SVP and President, Americas Lab and Distribution Services of VWR.  "We have a similar approach to supporting our customers by understanding customer requirements, then identifying solutions that leverage our knowledge, experience, resources and technology."

Established in 1999, Therapak has two locations in the United States and one in the United Kingdom totaling 240,000 square feet.  Therapak's services include standard and custom component and kit outsourcing, moderate to complex assembly, process control and serial labeling, packaging of courier, medical, diagnostic and pharmaceutical products in a variety of temperature sensitive materials and more. 

Financial details of this acquisition remain confidential.

About VWR  

VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is a leading, global, independent provider of products, services and solutions to laboratory and production facilities.  With sales in excess of $4.3 billion in 2014, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries.  With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production.  VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends.   Our dedicated team of more than 8,500 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.

For more information on VWR please visit www.vwr.com.

Media Contact:
Valerie Collado
Director, Corporate Communications
VWR International, LLC
484.885.9338
[email protected] 

Investor Contact:
John Sweeney, CFA
VP, Investor Relations
VWR Corporation
Phone: +610.386.1483
[email protected]

Logo - http://photos.prnewswire.com/prnh/20101109/NY97837LOGO

SOURCE VWR

Related Links

http://www.vwr.com